EVOLVING SCENARIO OF PHARMACEUTICAL CARE IN PAKISTAN AND OTHER COUNTRIES: HEALTH IMPACT ASSESSMENT IN PUBLIC HEALTH PRACTICE

被引:0
作者
Kousar, Saira Azhar Rozina [1 ]
Khan, Shumat Ali [1 ]
Murtaza, Ghulam [1 ]
机构
[1] COMSATS Inst Informat Technol, Dept Pharm, Abbottabad, Pakistan
来源
ACTA POLONIAE PHARMACEUTICA | 2016年 / 73卷 / 05期
关键词
pharmacist; pharmaceutical care; medicines; quality of life; harriers; skills; QUALITY-OF-LIFE; COMMUNITY PHARMACIES; SERVICES; PROVISION; PERCEPTIONS; OUTCOMES; SYSTEM; ASTHMA; SAFETY;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Worldwide. pharmaceutical care has been recognized as the primary mission of pharmacy. According to the philosophy of pharmaceutical care. pharmacist is not only responsible to dispense the medicines but also responsible to improve the patient's quality of life. Pharmaceutical care practice is required lobe introduced in the developing countries to decrease drug related mortality and morbidity. This paper aimed to highlight the quality of phamiaceutical care practice in the developing countries, predominantly in Pakistan. The paper highlights the health status and current scenario and barriers to pharmaceutical care practice in Pakistan. Pharmacists in Pakistan are not much involved in the provision of pharmaceutical care services due to a number of barriers that include insufficient number of pharmacists, lack of proper time, inadequate skills and training, lack of financial support and limited recognition of pharmacists in the public. A majority of community pharmacies are running without a pharmacist under the supervision of unprofessional personnel.
引用
收藏
页码:1101 / 1109
页数:9
相关论文
共 91 条
[1]  
Abah J.O., 2014, J BASIC CLIN PHARM, V25, P57
[2]  
Abdelhamid Elkhansa, 2008, Pharm Pract (Granada), V6, P25
[3]  
Abu-Gharbieh E, 2010, TROP J PHARM RES, V9, P421
[4]  
Adepu R., 2006, Indian Journal of Pharmaceutical Sciences, V68, P36
[5]  
Adepu R., 2011, ASIAN J PHARM CLIN R, V4, P2833
[6]  
Afzal U., 2013, LAHORE J EC, V12, P233
[7]  
AHI Ebid, 2006, BULL PHARM SCI 1, V29, P167
[8]  
Ahsan N., 2005, PAK DRUG UPDATES, V7, P4
[9]  
Akram M., 2007, PIDE WORKING PAPERS, V32, P19
[10]  
Albekairy A.M., 2014, J APPL PHARM SCI, V4, P70, DOI DOI 10.7324/JAPS.2014.40112